Sequential embolisation and renal cryoablation shows high efficacy and low severe adverse events in patients with renal ...
CAESAREA, Israel, Dec. 5, 2024 /PRNewswire/ -- IceCure Medical Ltd. (ICCM) (NASDAQ: ICCM) ('IceCure', 'IceCure Medical' or the 'Company'), developer of minimally-invasive cryoablation technology that ...
Percutaneous cryoablation of larger renal masses can be performed with high technical success and low complication rates, according to researchers. Grant D. Schmit, MD, and colleagues at Mayo Clinic ...
Identification of a molecular profile that may predict early relapse in patients undergoing multimodality therapy in muscle-invasive bladder cancer (MIBC). Background: Despite heightened awareness of ...
March 28, 2008 (Milan) — Despite increased perioperative complications, laparoscopic cryotherapy for larger (>3 cm) renal tumors is safe and feasible, with no increased risk for bleeding, according to ...
NEW ORLEANS—Percutaneous renal cryoablation is associated with durable oncologic outcomes and may represent an effective, minimally-invasive treatment option for small renal tumors, according to a new ...
The multidisciplinary panel thought the tumor’s proximity to the liver made it a bad candidate for percutaneous cryoablation therapy. A hand-assisted laparoscopic right partial nephrectomy was ...
For patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer by freezing – called cryoablation – yields a lower-risk of ...
IceCure Medical Ltd (NASDAQ:ICCM) shares are soaring in Monday's after-hours session after the company announced interim results from the ICESECRET study for the treatment of patients with small renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback